Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Anti-Cancer Drug Design|June 17, 1998
Antineoplastic agents 365. Dolastatin 10 SAR probesG R Pettit, J K Srirangam, J Barkoczy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinomaE Massarelli, H Lin, L E Ginsberg, et al.
Journal of Critical Care|May 13, 2019
Anti-Xa activity by weight in critically ill patients receiving unfractionated heparin for venous thromboembolism prophylaxisMeera V Aggarwal, Andrew S Jarrell, Vi T Gilmore, et al.
Pediatric Hematology and Oncology|February 5, 1999
Pediatric oncology and hematology in Birmingham, EnglandJ R Mann, P J Darbyshire, A Goodman, et al.
British Journal of Haematology|September 12, 2023
Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myelomaConnor M D Williams, Jacqueline E Noll, Alanah L Bradey, et al.
The Pharmacogenomics Journal|February 8, 2012
Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsisM Man, S L Close, A D Shaw, et al.
Indian Journal of Pediatrics|April 20, 2000
Poisoning in children: Indian scenarioA K Dutta, A Seth, P K Goyal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinomaR I Haddad, E Massarelli, J J Lee, et al.
Pageof 22